Cargando…
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
We performed a prospective study of circulating immune cell changes after stereotactic body radiotherapy (SBRT) in 50 early-stage NSCLC patients. We found no significant increase in CD8(+) cytotoxic T lymphocytes at first follow-up (the primary endpoint) but detected a significant increase in expand...
Autores principales: | Gkika, Eleni, Firat, Elke, Adebahr, Sonja, Graf, Erika, Popp, Ilinca, Radicioni, Gianluca, Lo, Simon S., Nestle, Ursula, Nicolay, Nils H., Niedermann, Gabriele, Duda, Dan G., Grosu, Anca-L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981559/ https://www.ncbi.nlm.nih.gov/pubmed/36864234 http://dx.doi.org/10.1038/s41698-023-00358-z |
Ejemplares similares
-
A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment
por: Duda, Dan, et al.
Publicado: (2023) -
Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies
por: Gkika, Eleni, et al.
Publicado: (2021) -
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017) -
Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
por: Gkika, Eleni, et al.
Publicado: (2017) -
FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy
por: Carles, Montserrat, et al.
Publicado: (2021)